We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

91 hedge funds and large institutions have $246M invested in Cytokinetics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $3.51M | Put options by funds: $1.35M

62% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 21

3% less capital invested

Capital invested by funds: $254M → $246M (-$8.08M)

4% less funds holding

Funds holding: 95 → 91 (-4)

22% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 18

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
91
Holders Change
-4
Holders Change %
-4.21%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
14
Increased
34
Reduced
21
Closed
18
Calls
$3.51M
Puts
$1.35M
Net Calls
+$2.17M
Net Calls Change
+$1.73M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.3M
2
State Street
State Street
Massachusetts
+$3.65M
3
Millennium Management
Millennium Management
New York
+$3.26M
4
Invesco
Invesco
Georgia
+$900K
5
Two Sigma Investments
Two Sigma Investments
New York
+$822K

Top Sellers

1
EC
EcoR1 Capital
California
-$13.5M
2
ACA
Avoro Capital Advisors
New York
-$4.78M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.17M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.1M
5
IHM
Iguana Healthcare Management
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
76
BlackRock
New York
$28K +$4.32K +414 +16%
PCM
77
Prelude Capital Management
New York
$27K +$14.6K +1,400 +93%
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$20.9K +$10.1K +964 +73%
LTFS
79
Ladenburg Thalmann Financial Services
Florida
$18K -$470 -45 -2%
GWM
80
Geneos Wealth Management
Colorado
$9K – – –
AG
81
Advisor Group
Arizona
$7K – – –
KF
82
Krilogy Financial
Missouri
$6K – – –
LWM
83
Lenox Wealth Management
Ohio
$6K – – –
Federated Hermes
84
Federated Hermes
Pennsylvania
$4K – – –
TRCT
85
Tower Research Capital (TRC)
New York
$2K -$5.15K -493 -69%
HR
86
Howe & Rusling
New York
$2K +$1.98K +190 New
PCA
87
Peddock Capital Advisors
Massachusetts
$2K +$2.73K +261 New
Creative Planning
88
Creative Planning
Kansas
$1K – – –
TCIM
89
TIAA CREF Investment Management
New York
$995 -$6.05K -580 -0.5%
VOYA Investment Management
90
VOYA Investment Management
Georgia
$169 – – –
ACA
91
Avoro Capital Advisors
New York
– -$4.78M -503,900 Closed
Acadian Asset Management
92
Acadian Asset Management
Massachusetts
– -$3.17M -334,284 Closed
IHM
93
Iguana Healthcare Management
New York
– -$1.42M -150,000 Closed
ACP
94
Acuta Capital Partners
California
– -$1.34M -140,969 Closed
EA
95
Emerald Acquisition
Washington
– -$1.22M -128,133 Closed
SO
96
STRS Ohio
Ohio
– -$678K -64,900 Closed
Prudential Financial
97
Prudential Financial
New Jersey
– -$527K -55,500 Closed
MCM
98
Matarin Capital Management
New York
– -$424K -44,720 Closed
SFM
99
Sphera Funds Management
Israel
– -$304K -32,069 Closed
Jacobs Levy Equity Management
100
Jacobs Levy Equity Management
New Jersey
– -$210K -22,130 Closed
1 2 3
4
5

CYTK Hedge Fund Activity: Q3 2016 in Review

91 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2016, worth a combined $246M — down 3.2% from $254M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CYTK and 14 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 34 added.

The largest buyer was Fidelity Investments, adding an estimated $18.3M. The largest seller was EcoR1 Capital, cutting an estimated $13.5M.

  • 91 institutional investors held Cytokinetics (CYTK) as of Q3 2016, down from 95 in Q2 2016.
  • Funds reported $246M of Cytokinetics stock for Q3 2016, down 3.2% quarter-over-quarter.
  • 14 funds opened new Cytokinetics positions in Q3 2016 and 18 closed out, a net change of -4 holders.
  • The largest Cytokinetics buyer in Q3 2016 was Fidelity Investments, an estimated $18.3M added.
  • The largest Cytokinetics seller in Q3 2016 was EcoR1 Capital, an estimated $13.5M sold.

Based on aggregated 13F filings for Q3 2016.